Uses organoids to test how a patient's tumor responds to drugs before treatment decisions are made.
Consented intake · your records travel with you · nothing moves without your sign-off
Vivodyne performs functional testing with organoids, applying drugs to fresh tumor tissue and observing the response over a two-day to six-week turnaround. The purpose is to give patients greater confidence, based on ex vivo results, that they will respond to a specific drug or combination. Access to fresh tumor tissue can be a limiting factor.
Prefer the source? Vivodyne (organoids)'s own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Vivodyne (organoids) handles billing.
We don't have confirmed insurance details for Vivodyne (organoids) yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Vivodyne's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.